SINOCELLTECH: CSRC seeks supplementary filing materials on HK listing rationale, litigation

NewTimeSpace News: On 18 September 2026, the International Department of the CSRC issued supplementary material requirements for SinoCellTech's overseas issuance and listing filing, covering six items.

Regarding outbound investment, the CSRC requires an explanation of the performance of regulatory procedures for outbound investment and foreign exchange management in connection with the Company's establishment of overseas subsidiaries, together with a definitive opinion on compliance. Regarding the proceeds, the CSRC requires an itemised statement of the specific amounts and proportions of the proceeds to be used for domestic and overseas investment projects and an explanation of the relevant approval, authorisation or filing procedures, and, where such procedures are in progress, an undertaking that all proceeds will be repatriated to the PRC. Regarding litigation, the CSRC requires an explanation of all outstanding litigation and arbitration involving the Company, whether such matters will have a material adverse effect on its future operations, whether they constitute a material obstacle to the offering, and whether they have been fully disclosed.

In addition, the CSRC requires the Company to further explain, in light of the intended use of proceeds, the necessity and reasonableness of its listing in Hong Kong; to explain, in light of debt-servicing capacity, whether share pledges and loan guarantees before and after completion of the offering may give rise to material ownership disputes or cause a change in the controlling shareholder; and to explain the specific operations of its property management business.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.